Medication non-adherence is a big problem. It's a 290 billion dollar problem in the US annually. Fifty percent of us don't take medications as we should. So Orbis wants to take a lot of that error out of the hands of the patient, and put it back into the dosage form. We use precision particle fabrication to create particles that are very uniform and unique things. If you want to inject a particle, there's a certain optimal size. If you want to control the release rate for weeks or days, there's a certain optimal size. So on the left; you can see an example of Orbis' technology. On the right you can see particles made from the exact same material from a different manufacturing process. All the particles are different sizes, there's no sort of uniformity. You can deal with that later, you can sieve off some of the particles and try to find the right ones, but Orbis can actually do that from the very beginning. For kids, taste is one of the biggest problems, so we use this technology to mask the taste, so that you don't taste anything. We recently produced a four to five kilogram batch, and we have the capacity to create scales that are large enough to address clinical trial need right now. Pharmaceutical companies can leverage this technology to differentiate their products. Maybe they need to make it long acting, or there's a taste issue, or they need a new format. This allows them to introduce differentiated products into their portfolio. These are the things you can't do with other technologies.